Risk Model for Metastasis Detection of Neuroblastoma

Enrolling by invitationOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

July 1, 2025

Study Completion Date

December 1, 2026

Conditions
Neuroblastoma (NB)PrognosisBone Marrow MetastasisBone Metastases
Interventions
OTHER

risk model in diagnosis and prognosis

"In this study, we construct and evaluate the bone marrow cytology-based AI model for detection and prognosis of NB.~1. For the diagnostic model, we use AUC metrics to evaluate the model in terms of sensitivity, specificity, accuracy, positive predictive value and negative predictive value at different classification thresholds.~2. For the prognostic model, we use AUC as the performance metric and calculating sensitivity and specificity. Survival curves were constructed according to the Kaplan-Meier method."

Trial Locations (3)

200092

Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai

518038

Shenzhen Children's Hospital, Shenzhen

Unknown

The Children's Hospital, Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
collaborator

Shenzhen Children's Hospital

OTHER_GOV

collaborator

The Children's Hospital of Zhejiang University School of Medicine

OTHER

lead

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

OTHER